Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, May 6, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Legal
Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation
Life Sciences Times
-
December 20, 2021
0
Public Health
Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply
Life Sciences Times
-
December 20, 2021
0
Medtech
Bruker Introduces Fast BioAFM for Automated Mechanobiology
Life Sciences Times
-
December 20, 2021
0
People on the Move
Affinivax Appoints Vanya Sagar as Chief People Officer
Life Sciences Times
-
December 16, 2021
0
People on the Move
Surgical Innovation Associates Raises $15 Million in Oversubscribed Series B Round, Appoints Veteran Medtech CEO
Life Sciences Times
-
December 16, 2021
0
Pharma
Axcella Therapeutics Announces Initiation of AXA1125 Long COVID Phase 2a Clinical Trial
Life Sciences Times
-
December 16, 2021
0
Venture Capital
ILC Dover Acquires KSE Scientific, a Leading Supplier of Water for Injection and Related Solutions for Biopharma, Cell & Gene Therapy, Tissue Banking and...
Life Sciences Times
-
December 16, 2021
0
Pharma
EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in independent FDA study
Life Sciences Times
-
December 16, 2021
0
Pharma
Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement
Life Sciences Times
-
December 16, 2021
0
Venture Capital
Verge Genomics Secures $98 Million in New Financing
Life Sciences Times
-
December 16, 2021
0
1
...
684
685
686
...
834
Page 685 of 834
Most Popular
Vertex Reaches German Reimbursement Agreement for CASGEVY
May 6, 2026
908 Devices Raises 2026 Revenue Outlook After First-Quarter Growth
May 6, 2026
CellCentric Raises $220 Million to Advance Multiple Myeloma Drug Trials
May 6, 2026
City Therapeutics Reports Preclinical Data for Stargardt Disease RNAi Therapy
May 6, 2026
Load more
Recent Comments
Recent Comments